• BASF reviews strategic options for subsidiary trinamiX, announces new management
LUDWIGSHAFEN, Germany – Chemical company BASF announced on January 26 that it is examining strategic options for its subsidiary trinamiX GmbH, a process that includes a change in management and may involve the sale of business units.
What is new?
BASF is undertaking a strategic review of trinamiX GmbH as part of a new corporate strategy to focus on its core business. The company stated that trinamiX’s specializations in biometric imaging and mobile material analysis are not part of this core business.
The re-evaluation will center on restructuring, cost efficiency, and value optimization.
Management Changes
As part of the reassessment, a change in leadership is taking place. Dr. Ingmar Bruder, the managing director who has led trinamiX since its foundation, departed from the management board on January 26, 2026. He will be succeeded by Dr. Lothar Laupichler, effective February 1, 2026. Dr. Laupichler most recently served as the head of BASF’s global electronic materials business. Sören Bauermann, who has been on the trinamiX management team since 2023, will remain on the board.
Strategic Context
The examination of strategic options for trinamiX is a direct result of BASF’s implementation of a new corporate strategy. The company is concentrating its resources and focus on its primary operations. The process for trinamiX may include the sale of individual business areas, though no final decisions have been announced.
About this company
trinamiX GmbH was founded in 2015 as a subsidiary of BASF SE and is headquartered in Ludwigshafen, Germany. The company develops solutions based on biometric imaging and mobile NIR spectroscopy. It employs approximately 200 people worldwide and holds more than 800 patents and patent applications.